Anti-proliferative pharmaceutical composition
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 25, 2012
Grant Date -
Aug 24, 2006
app pub date -
Apr 21, 2006
filing date -
Dec 9, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The use of urocanic acid or another pharmaceutically acceptable agent being able to acidify the cell cytoplasm for the manufacture of a pharmaceutical composition useful for causing inhibition or halting of transformed or non-transformed cell proliferation in a person or an animal, where an effective amount of the agent is administered in an essentially non-dissociated form to the person or animal. The use of the agent as an enhancer for other therapeutically active agents, and a pharmaceutical composition, are also disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully